Harlan F Weisman
CIK 1555563 · President and CEO · last filed 2024-07-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
14
Lifetime Open-Market Net
$600.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TFF Pharmaceuticals, Inc. (TFFP) Delisted | President and CEO | 842,095 | $0.07 | $54.7K | $409.9K | 11 | 2024-07-08 |
| Fortress Biotech, Inc. (CNDO) Delisted | Chairman and CEO | 30,000 | — | — | $190.1K | 3 | 2013-06-21 |
Recent Filings · Page 2 of 2
14 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-10-29 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Mixed | +5,000 | $25.0K | EDGAR |
| 2013-06-21 | Fortress Biotech, Inc. (CNDO) Delisted | Buy (P) | +10,000 | $75.9K | EDGAR |
| 2013-01-15 | Fortress Biotech, Inc. (CNDO) Delisted | Buy (P) | +20,000 | $114.2K | EDGAR |
| 2013-01-09 | Fortress Biotech, Inc. (CNDO) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–14 of 14
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.